CD4 and tuberculosis: Consistent with Mupfumi et al. (2020), we found a significant reduction in activation marker expression within MTB-specific T cells [13,16,17] but not within total CD4+ T-cells at 2 months of TB treatment, which were more pronounced in the HIV coinfected patients compared to the HIV-negative TB patients.